Oxford COVID-19 Vaccine Trial Paused After Participant Falls Ill

by GoNews Desk 3 years ago Views 3814

Oxford COVID-19 Vaccine Trial Paused After Partici
The University of Oxford, which is at the forefront of making the coronavirus vaccine with AstraZeneca, has paused its trial after a participant fell ill during the trial. However, the University described it as a ‘routine’ pause during the trial and it can be started soon.

The trials of Oxford University and AstraZeneca, which is in the most advanced stage, is closely being watched around the world.

The phase 3 trial of the vaccine involves about 30,000 people in many countries. Till Tuesday, 17,000 participants in the UK, Brazil and South Africa have been given the dose. The results so far suggest that antibodies have developed in those who were vaccinated.

Apart from Britain, its trial is going on in countries like the US, Brazil, India and South Africa.

Experts associated with the trial of Corona vaccine say that till now only six vaccine trials have reached the third stage, which considered to be the most important stage before the approval of the vaccine.

However, during this time a participant fell ill and the trial has to be stopped in all countries, a setback for the team involved in developing the vaccine.

The statement issued by Oxford and AstraZeneca said: "In large trials, illnesses will happen by chance but must be independently reviewed to check this carefully."

If this disruption does not take much time, then the Oxford vaccine may become available in the market by January 2021. Many countries are looking at the Oxford University vaccine with great hope. Meanwhile, Australia has also signed a $1.7 billion deal to get all its citizens vaccinated for free. Australian Prime Minister Scott Morrison said on Monday that his government would buy 33.8 million doses of the vaccine if it worked.

Latest Videos

Latest Videos

Facebook Feed